tiprankstipranks
Trending News
More News >

Adaptive Biotechnologies price target raised to $11 from $7 at Piper Sandler

Piper Sandler raised the firm’s price target on Adaptive Biotechnologies (ADPT) to $11 from $7 following quarterly results. The firm keeps an Overweight rating on the shares.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue